TNF Pharmaceuticals ( (TNFA) ) has released a notification of late filing.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
TNF Pharmaceuticals has announced a delay in filing its Form 10-Q (Quarter Report) for the financial period ending June 30, 2025. The company cites the need for additional time to complete and finalize its financial statements as the primary reason for the delay. TNF Pharmaceuticals expects to file the report within five calendar days following the prescribed due date. The company does not anticipate any significant changes in its financial results compared to the previous year. TNF Pharmaceuticals is committed to maintaining compliance and has ensured all other required reports have been filed. The notification was signed by Joshua Silverman, Director, on August 14, 2025.
More about TNF Pharmaceuticals
Average Trading Volume: 34,539,732
Technical Sentiment Signal: Strong Sell
Current Market Cap: $1.56M
Learn more about TNFA stock on TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money